Duopharma, the Malaysia pharma company behind the vitamin brand Flavettes, has outlined its strategies in growing the consumer healthcare business - including expanding the flagship brand across South East Asia and developing new immunity and energy products.
Experts have weighed in on the importance of educating consumers on the concept of healthy ageing, and upcoming innovations in ingredients and delivery formats to drive the concept in the rapidly ageing Asia-Pacific region.
Australian health and wellness company Eve Investments is launching its honey and tea tree oil sold under the brand Meluka Australia into more parts of APAC amid high growth in China on the back of consumer immunity concerns.
See September's 10 most read stories, including the launch of probiotic curd from Indian brand Milky Mist, the most commonly reported side effects of probiotics, omega-3 supplementation in South Korea and more.
New Zealand’s Anagenix, the winner of the prebiotic ingredient of the year award in this year’s NutraIngredients-Asia and USA awards, has revealed new scientific findings on its ingredient, including how it could improve stool form and increased bowel...
In this round-up of new scientific findings, we look at how probiotics supplementation could bring about cardio benefits, how companies such as Anagenix has turned to online arrangements for its clinical trial and more.
Moving fast and quick is crucial to tap on the “tremendous opportunities” that the South East Asia (SEA) market presents, according to Bayer’s ASEAN head who also spoke about the firm’s recent partnership with an airline and its promotional Tiktok dance...
Supplement and functional food firm Amado Thailand is consolidating the benefits of both online and offline as it remains on course to hit its annual sales target of THB$2500m (US$79m), despite the economic challenges brought by COVID-19.
MGC Pharma is registering a botanical and vitamin supplement that is currently being trialled on COVID-19 patients for sale in Slovenia, while the long-term goal is to launch it as a pharmaceutical product.